If you need more lookups,
subscriptions start at $34 USD/month.
Alberto Visintin Location
Boston, MA, US
Alberto Visintin Work
2022 -now Sr. Director - Translational Research @
2020 -2022 Sr. Director - Head of Research and Development @ Genocea
2016 -2020 Principal Scientist (Dir) - Translational Medicine @
2015 -2016 Full Time Consultant, External research @
2010 -2015 Associate Research Fellow (AD), Anti Cancer Therapeutic Antibodies @
2007 -2010 Lab Head, Target ID and Immune Adjuvants @
2003 -2007 Research Assistant Professor, Innate Immunity @
2001 -2003 Instructor @
1997 -2001 Post Doctoral Fellow, Innate Immunity @
1995 -1997 Trainee and Conscience Objector @ National Cancer Institute, CRO
Alberto Visintin Education
Università degli Studi di Trieste
Doctor in Biological Sciences (DSC) (Doctor in Biological Sciences (DSC), Molecular Biology)
Alberto Visintin Skills
In Vitro
Intellectual Property
High Throughput Screening
Research
Antibody Drug Conjugates
Biochemistry
Healthcare
Protein Chemistry
Management
Confocal Microscopy
Toll Like Receptors
Oncology
Antibodies
Biotechnology
Molecular Biology
Cell Based Assays
Cancer
Project Management
Cell
Cell Culture
Animal Models
Biotherapeutics
Drug Discovery
Cell Biology
Innate Immunity
Phage Display
Immunology
Public Speaking
Strategy
Leadership
Assay Development
Alberto Visintin Summary
Alberto Visintin, based in Boston, MA, US, is currently a Sr. Director - Translational Research at Compass Therapeutics Inc.. Alberto Visintin brings experience from previous roles at Genocea, Merck, Idera Pharmaceuticals and Pfizer. Alberto Visintin holds a Doctor in Biological Sciences (DSC) in Doctor in Biological Sciences (DSC), Molecular Biology @ Università degli Studi di Trieste. With a robust skill set that includes In Vitro, Intellectual Property, High Throughput Screening, Research, Antibody Drug Conjugates and more. Alberto Visintin has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Alberto Visintin?
Find contact details for 700 million professionals.